Bispecific protein targets prostate cancer - Wikidata - wikimedia - TriplyDB

Bispecific protein targets prostate cancer

Bispecific protein targets prostate cancer

http://www.wikidata.org/entity/Q42335076

about

Bispecific protein targets prostate cancer

http://www.wikidata.org/entity/Q42335076

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Bispecific protein targets prostate cancer

@en

Bispecific protein targets prostate cancer

@nl

type

label

Bispecific protein targets prostate cancer

@en

Bispecific protein targets prostate cancer

@nl

prefLabel

Bispecific protein targets prostate cancer

@en

Bispecific protein targets prostate cancer

@nl

P1433

Q42335076-2E10A9CE-4730-4560-AFC0-4D469330F842

P1476

Q42335076-388739BF-5B1A-428F-8E95-D6ABB8496989

P2093

Q42335076-8F5E1668-D385-43E0-A806-535F0B0EDCEB

P2860

Q42335076-0F68C023-B708-4885-B38E-75CE100A9443

Q42335076-45928E07-A9B2-4C8A-B9E8-2F29B2547EA6

Q42335076-4DFFC3E8-7C30-43E3-9560-52220F81A392

Q42335076-7690816F-4410-4BE1-A1C5-778D28DD1683

Q42335076-BC6699F8-9D1C-4FF9-A525-08D1B9F172A1

Q42335076-F763E78E-350A-4676-8B92-6EAE11460D2E

P304

Q42335076-3E0F7F87-9147-44F7-86FC-20CB78DB6AB5

P31

Q42335076-93CE3020-F8B8-431D-B458-8701DB16D435

P356

Q42335076-1933A50B-2961-4C10-BE18-E46D31C67556

P407

Q42335076-F66A1416-A89D-4426-B78B-9BC023471193

P433

Q42335076-BD23746F-443F-4E99-ACCC-E2BD796C197E

P478

Q42335076-51F2A3C4-BB86-4C00-BF84-33E908C771A3

P577

Q42335076-58577403-2FAA-4873-BC5C-72FD09F33ABE

P698

Q42335076-BD6CEEC5-AB7C-4D93-A123-D6E64EC38561

P932

Q42335076-91D1114C-E940-4C3A-A0F1-9EF5CFA577BA

P356

ONCOTARGET.17372

P1433

P1476

Bispecific protein targets prostate cancer

@en

P2093

Antony W Burgess

http://www.w3.org/2001/XMLSchema#string

P2860

EGFR-homing dsRNA activates cancer-targeted immune response and eliminates disseminated EGFR-overexpressing tumors in mice.

Radioimmunotherapy of Metastatic Prostate Cancer with ¹⁷⁷Lu-DOTAhuJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody.

From the Guest Editor: The Spectrum of Treatment of Metastatic Prostate Cancer: Present and Future.

Leverage nonclinical development of bispecifics by translational science.

PSMA-homing dsRNA chimeric protein vector kills prostate cancer cells and activates anti-tumor bystander responses

Revised Overall Survival Analysis of a Phase II, Randomized, Double-Blind, Controlled Study of PROSTVAC in Men With Metastatic Castration-Resistant Prostate Cancer.

P304

35484-35485

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.17372

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28455964

http://www.w3.org/2001/XMLSchema#string

P932

5482589

http://www.w3.org/2001/XMLSchema#string